Target intelligence / Profile preview

WD repeat domain phosphoinositide-interacting protein 4 (WDR45)

Target
WDR45
Molecular classification
Autophagy protein, WD repeat family protein, Beta-propeller scaffold protein, Phosphoinositide-binding protein, Other
01

Overview

WD repeat domain phosphoinositide-interacting protein 4 (WDR45; also known as WIPI4) is an evolutionarily conserved member of the WD repeat protein family characterized by a seven-bladed beta-propeller structure. It acts as a scaffold for protein-protein interactions in the assembly of autophagy machinery, promoting autophagosome formation and elongation and ensuring the degradation and recycling of unwanted proteins and organelles. WDR45 binds phosphoinositides via a conserved motif, facilitating recruitment to membranes where autophagosomes initiate. It also participates directly in regulating stress granule disassembly dynamics under cellular stress conditions. In humans, loss-of-function mutations in the WDR45 gene cause beta-propeller protein-associated neurodegeneration (BPAN), a subtype of neurodegeneration with brain iron accumulation (NBIA) characterized by early developmental delay, epilepsy, progressive intellectual decline, movement disorders, and iron accumulation in the brain visible on MRI. WDR45 dysfunction leads to impaired autophagy and ferritinophagy, causing cellular iron overload, oxidative stress, and mitochondrial dysfunction. Currently, WDR45 is a disease gene but is not a direct pharmacological target for any approved therapies.

Other names
WIPI4WD repeat domain 45WD repeat-containing protein 45WD45 repeat protein interacting with phosphoinositides 4WD repeat domain, X-linked 1JM5NBIA4NBIA5WDRX1WDRXI4WIPI-4
02

Mechanism of action

Not applicable (no known direct WDR45-targeting drugs). Mechanistically, loss-of-function causes impaired autophagy, altered stress granule dynamics, and intracellular iron overload, but these are not targeted by current therapeutic agents.

03

Biological functions

Regulation of autophagy (controls autophagosome biogenesis and elongation)Intracellular protein and organelle turnover (clearance of unneeded materials)Regulation of intracellular iron homeostasis (via ferritinophagy)Signal transduction (modulates mTOR, AMPK, ULK1 signaling)Protein-protein interaction scaffold (through WD repeats)Stress granule disassembly and dynamics
04

Disease associations

Neurodegenerative disease (notably beta-propeller protein-associated neurodegeneration / BPAN)Iron metabolism disorder (due to impaired ferritinophagy and iron accumulation)Epilepsy (in the context of BPAN)Developmental and intellectual disabilities (BPAN)
05

Safety considerations

Therapeutic targeting is challenging due to the essential role of WDR45 in numerous cellular processes including autophagy and neuronal maintenance.Loss-of-function or inhibition may result in neurodegeneration, iron accumulation, cellular stress, and impaired cellular repair.
06

Interacting drugs

None currently approved or well-characterized in the literature; no specific, direct small-molecule or biologic targeting WDR45 is available as of 2024
07

Biomarkers

Mutations in WDR45 are used as diagnostic biomarkers for BPAN (Beta-propeller protein-associated neurodegeneration).Brain iron accumulation visible by MRI (NBIA)

Beyond the preview

Go deeper on WD repeat domain phosphoinositide-interacting protein 4 (WDR45).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat domain phosphoinositide-interacting protein 4 (WDR45).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call